Cancer Family
Central Nervous System Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000116Explore in graph →
HematologicNon-malignant83 active trials1 approved drugs
- NCIt
- C5503
Loading cancer entity…
Cancer Family
CI-CAN-00000116Explore in graph →
Clinical trials
224 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05651178 | Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients | active not recruiting | Early Phase 1 | 10 | Hrain Biotechnology Co., Ltd.INDUSTRY | 1 | Jun 4, 2026 | clinicaltrials |
| NCT03684980 | LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma | active not recruiting | Early Phase 1 | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 15, 2026 |
Data updated 23 days agoSource updated Jun 4, 2026source: clinicaltrials